Review
doi: 10.1093/jac/dki079.
Epub 2005 Mar 16.
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update
Affiliations
- PMID: 15772142
- DOI: 10.1093/jac/dki079
Item in Clipboard
Review
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update
J Antimicrob Chemother.
2005 May.
Abstract
Interest in the relationships between the pharmacokinetics (PK) and pharmacodynamics (PD) of antimicrobial agents has increased over recent years. Since the appearance 2 years ago of our first article describing terminology in PK/PD, the field has continued to expand rapidly, urgently requiring an update. This paper describes in a uniform manner the use of PK/PD expressions for antimicrobial agents, and their units.
Similar articles
-
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs.Int J Antimicrob Agents. 2002 Apr;19(4):355-8. doi: 10.1016/s0924-8579(02)00031-6. Int J Antimicrob Agents. 2002. PMID: 11978507
-
Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.J Vet Pharmacol Ther. 2004 Dec;27(6):503-14. doi: 10.1111/j.1365-2885.2004.00603.x. J Vet Pharmacol Ther. 2004. PMID: 15601444 Review.
-
AUC/MIC: a PK/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor?J Antimicrob Chemother. 2007 Dec;60(6):1185-8. doi: 10.1093/jac/dkm360. Epub 2007 Oct 11. J Antimicrob Chemother. 2007. PMID: 17932075
-
Fluoroquinolone benchmarking in relation to pharmacokinetic and pharmacodynamic parameters.J Antimicrob Chemother. 2003 May;51 Suppl 1:43-7. doi: 10.1093/jac/dkg211. J Antimicrob Chemother. 2003. PMID: 12702703 Review.
-
Antimicrobial susceptibility breakpoints: PK-PD and susceptibility breakpoints.Treat Respir Med. 2005;4 Suppl 1:5-11. Treat Respir Med. 2005. PMID: 15846151 Review.
Cited by
-
Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1295-301. doi: 10.1007/s10096-013-1878-9. Epub 2013 Apr 23. Eur J Clin Microbiol Infect Dis. 2013. PMID: 23609512
-
Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy.Front Pharmacol. 2022 Oct 18;13:1024608. doi: 10.3389/fphar.2022.1024608. eCollection 2022. Front Pharmacol. 2022. PMID: 36330086 Free PMC article.
-
An LC-MS/MS method for the simultaneous determination of 18 antibacterial drugs in human plasma and its application in therapeutic drug monitoring.Front Pharmacol. 2022 Nov 8;13:1044234. doi: 10.3389/fphar.2022.1044234. eCollection 2022. Front Pharmacol. 2022. PMID: 36425576 Free PMC article.
-
Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.Br J Clin Pharmacol. 2010 Aug;70(2):201-12. doi: 10.1111/j.1365-2125.2010.03679.x. Br J Clin Pharmacol. 2010. PMID: 20653673 Free PMC article.
-
Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy.Pharmaceutics. 2022 Apr 11;14(4):842. doi: 10.3390/pharmaceutics14040842. Pharmaceutics. 2022. PMID: 35456676 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
